[Federal Register Volume 63, Number 76 (Tuesday, April 21, 1998)]
[Notices]
[Page 19737]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-10437]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given of the
meeting of the National Advisory Council on Drug Abuse, National
Institute on Drug Abuse (NIDA) on May 19-20, 1998, at the National
Institutes of Health, Natcher Building 45, 9000 Rockville Pike,
Bethesda, MD 20892.
On May 19, from 9 a.m. to 4 p.m., the meeting will be held in
Conference Rooms E1, E2, G1 and G2. In accordance with provisions set
forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. and
section 10(d) of Public Law 92-463, this portion of the meeting will be
closed to the public for the review, discussion, and evaluation of
grant applications. These applications and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications, disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
On May 20, from 9 a.m. to 5 p.m., the meeting will be held in
Conference Rooms E1 and E2. This portion of the meeting will be open to
the public for annoncements and reports administrative, legislative,
and program developments in the drug abuse field. Attendance by the
public will be limited to space available.
A summary of the meeting and a roster of committee members may be
obtained from Ms. Camilla L. Holland, NIDA Committee Management
Officer, National Institutes of Health, Parklawn Building, Room 10-42,
5600 Fishers Lane, Rockville, Maryland 20857, (301/443-2755).
Substantive program information may be obtained from Dr. Teresa
Levitin, Room 10-42, Parklawn Building, 5600 Fishers Lane, Rockville,
Maryland 20857, (301/443-2755).
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
contact Dr. Levitin in advance of the meeting.
(Catalog of Federal Domestic Assistance Program Numbers: 93.277,
Drug Abuse Research Scientist Development and Research Scientist
Awards; 93.278, Drug Abuse National Research Service Awards for
Research Training; 93.279, Drug Abuse Research Programs)
Dated: April 14, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-10437 Filed 4-20-98; 8:45 am]
BILLING CODE 4140-01-M
